Skip to main content
OpenTrials
Completed

NCT Number: NCT06722404

Synbiotics for the Management of Malnutrition (Children)

In this study, dose related effect of synbiotics on the blood indices of severely acute malnourished (SAM) children (6-59 months) was carried out in hospitalized setting. Fifty SAM children were enrolled in a double-blind, randomized design.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–59 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nutrition Rehabilitation Unit (NRU), Department of Social & Preventive Pediatrics, Mayo Hospital,

Lahore, Punjab Province, 54000, Pakistan

About this study

The study was done at Nutrition Rehabilitation Unit (NRU), Department of Social & Preventive Pediatrics, Mayo Hospital, Lahore, Pakistan, a Tertiary Care large urban teaching and referral hospital and was approved by human ethics Institutional Review Board (IRB) .Galacto-oligosaccharides (Oligomate) as prebiotics were procured from Yakult Pharmaceutical Industry, Japan and Resiton (lactobacillus paracasei subsp. paracasei) as probiotics were procured from MakNsons Pharmaceutical Industry, Italy. In the present study we enrolled 50 severely acute malnourished (SAM) in patients of 6-59 months of age while follow-up treatment was given at the out-patient department. We define SAM as weight-for height of less than 70% of the median, nutritional edema (Kwashiorkor), or both, mid-upper arm circumference (MUAC) of less than 11.5cm. Anthropometry protocols were followed by research standards

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • In the present study we enrolled 50 severely acute malnourished (SAM) patients of 6-59 months of age while follow-up treatment was given at the out-patient department.
  • Patients having weight-for-height of less than 70% of the median, nutritional edema (Kwashiorkor), or both,
  • mid-upper arm circumference (MUAC) of less than 11.5cm

Exclusion criteria

  • Participant taking other supplements or enrolled in other studies

Treatment and study plan

Standard therapeutic foods

Dietary Supplement

All children were initially fed F-75 (75 kcal/ 100mL) therapeutic milk (Phase I) and then progressed to F-100 (100 kcal/ 100mL) (Phase II) and Plumpy'nuts (F-100 in spread form with iron fortification) (Phase III) with follow-up for 48 days

Therapeutic foods plus Synbiotics

Combination Product

the intervention group received therapeutic foods plus synbiotics containing Oligomate that was fortified in F75 at the rate of 7.5 g/L containing 4.1 g/L GOS for 1 g/100 kcal dose and at the rate of 11.5 g/L containing 6.1 g/L GOS for 1.5 g/100 kcal dose while in F100 and Plumpy'nuts it was fortified at the rate of 10 g/L containing 5.5 g/L GOS for 1 g/100 kcal dose and at the rate of 15 g/L containing 8.25 g/L GOS for 1.5 g/100 kcal dose and Resiton (Lactobacillus paracasei sbsp. paracasei) 3 billion cfu/day and 6 billion cfu/day that were mixed in different combinations.

Primary outcomes

  1. Weight

    Time frame: 48 days

    weight change observed in patients

  2. Number of Stools

    Time frame: 48 days

    Number of stools per day

Secondary outcomes

  1. Complete blood count (CBC)

    Time frame: 48 days

    For hematological and biochemical screening 5 mL venous blood was taken after 12 h fasting in vacutainers tubes containing ethylenediamine tetra-acetic acid (EDTA). Complete blood count (CBC) was carried out using haemocytometer

  2. Serum albumin levels

    Time frame: 48 days

    The assay is based on the selective interaction between BCG and albumin forming a chromophore that can be detected at 620 nm using spectrophotometer. The signal is directly proportional to the amount of albumin present in the serum. BCG does not react with other abundant plasma proteins like IgG

  3. serum electrolytes

    Time frame: 48 days

    Serum electrolytes such as Na and K were analyzed by electrolyte analyzer (Biolyte 2000; BioCare Corporation, Taiwan). Briefly, 10 mL blood was obtained from each subject and then blood samples were allowed to stand for 1 h to clot. Thereafter, blood samples were centrifuged at 300 rpm, 15 min at room temperature. The supernatant was then separated from the settled bottom blood cells

  4. ESR determination

    Time frame: 48 days

    anti-coagulated blood was allowed to stand in a narrow vertical glass tube, undisturbed for a period of time, the RBCs under the influence of gravity settled out from the plasma. The rate at which they settled was measured as the number of millimeters of clear plasma present at the top of the column after one hour (mm/h).

  5. SGPT/ ALT

    Time frame: 48 days

    ALT is an important indicator of liver disease. The series of reactions involved in the assay system is as follows; L-Alanine + 2- oxoglutarate → Pyruvate + L-Glutamate; Pyruvate + NADH → Lactate+ NAD. Then this rate of Nicotinamide adenine dinucleotide (NADH) consumption is determined photo metrically that is proportional to ALT activity in the sample.

  6. SGOT/ AST

    Time frame: 48 days

    The AST is the cellular enzyme, is found in highest concentration in heart muscle, the cells of the liver and the cells of the skeletal muscle. The rate of decrease in concentration of NADH, measured photometrically at 340 nm is proportional to the catalytic concentration of AST present in the sample.

  7. Alkaline Phosphatase

    Time frame: 48 days

    For the determination of alkaline phosphatase, the following protocol was adopted . Alkaline phosphatase release phenol from para nitrophenylphosphate, the phenol in alkaline medium gives yellow color which can be estimated with spectrophotometer at 405 nm. The reagents required for this experiment are R1=diethanolamine (pH 9.8, 1.2 mol/L), magnesium chloride (0.6 mmol/L); R2=p-nitrophenylphosphate (50 mmol/L).

Sponsors and collaborators

Lead sponsor

University of Veterinary and Animal Sciences, Lahore - Pakistan

Other

Registry information

Official study title

Effect of Synbiotics on Hematological Indices of Malnourished Children

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Dec 9, 2024
Registry last updated
Dec 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.